AGEN ▼ -1.0% - Agenus Inc.
$AGEN Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
03-OCT-2026 11:02 AM ET
Share this post
More filings for $AGEN
AGEN ▲ +1.1% - Agenus Inc.Oct 2, 2026$AGEN SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 27, 2026$AGEN SEC Filing Update (20-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 20, 2026$AGEN SEC Filing Update (17-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 17, 2026
View full $AGEN filing history →💬 Comments
Loading comments…
Leave a comment